Technetium (99mTc) pentetic acid
Appearance
Clinical data | |
---|---|
Trade names | Draximage DTPA |
License data | |
Routes of administration | Intravenous, inhalation |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C14H18N3NaO10Tc |
Molar mass | 509 g·mol−1 |
3D model (JSmol) | |
Technetium (99mTc) pentetic acid, sold under the brand name Draximage DTPA among others, is a radiopharmaceutical medication used in nuclear medicine to image the brain, kidneys, or lungs.[1] It is given by intravenous injection or via aerosol spray.[1] It consists of technetium-99m bound to the conjugate base of pentetic acid, with sodium as an additional cation.
Medical uses
[edit]Technetium (99mTc) pentetic acid is indicated for use in the diagnosis of the brain, kidneys, or lungs.[1]
References
[edit]- ^ Jump up to: a b c d "Draximage DTPA- kit for the preparation of technetium tc 99m pentetate injection, powder, lyophilized, for solution". DailyMed. 8 November 2022. Archived from the original on 5 February 2023. Retrieved 4 February 2023.